Journal article

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization

A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1–29 year olds was conducted in Burkina Faso in December 2010. Protection of subsequent infant cohorts will be necessary through either introduction of PsA-TT into the routine Expanded Programme on Immunization (EPI) or periodic repeat mass vaccination campaigns.

Languages

  • English

Publication year

2015

Journal

Vaccine

Volume

12

Type

Journal article

Categories

  • Programme management

Diseases

  • Measles

Countries

  • Burkina Faso

Tags

  • Coverage monitoring
  • New vaccine introduction

WHO Regions

  • African Region

Added by: Moderator

Added on: 2015-11-15 09:17:39

Hits: 999